PFE - GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon Raises Over £900M | Benzinga
Tuesday, GSK plc (NYSE:GSK) announced to sell 300 million ordinary shares in Haleon plc (NYSE:HLN) at 326 pence per share, raising gross proceeds of approximately £978 million.
Following the settlement of the Placing, GSK will hold approximately 385 million ordinary shares in Haleon, representing approximately 4.2% of the issued share capital of Haleon.
GSK and Pfizer Inc (NYSE:PFE) (which holds a 32% stake in Haleon) have each undertaken not to dispose of any further shares in Haleon for 60 days following settlement ...